
CEO @KDrazan will join a panel tomorrow, March 4, 3:30-4:30pm, at #PMWC26, where they will discuss Gene Editing & Synthetic Biology for Therapy. More: bit.ly/40DVqfx #Biotech #Oncology

We’re a programmable clinical-stage cell therapy company focused on the realization of solid tumor cell therapies. Our purpose is very clear: defeat cancer.

CEO @KDrazan will join a panel tomorrow, March 4, 3:30-4:30pm, at #PMWC26, where they will discuss Gene Editing & Synthetic Biology for Therapy. More: bit.ly/40DVqfx #Biotech #Oncology

Today at the Evolution Summit, ArsenalBio’s Farah Anwar will share insights on CAR-T cell therapy and its potential to redefine the future of personalized cancer treatment. More here: bit.ly/3LIZpn9 #CancerResearch

This Wednesday, ArsenalBio’s Farah Anwar will join a panel of clinical trial experts to share strategies for balancing scientific rigor, operational efficiency, and the patient experience. More on the webinar: bit.ly/48Hyn7a #celltherapy #clinicaltrials

Heading to @AdTherapiesConf USA 2025 this week? Check out one of the sessions where Christopher Murriel will share insights on #celltherapy development. bit.ly/3X1QJdU #adtherapies #cancerresearch

We’re gearing up for #SITC2025! We will share the latest research on our lead investigative cell therapy intended for mCRPC, CAR T cell therapy design, and our foundation model predicting targets for overcoming T cell exhaustion. Join us Nov 7–9: bit.ly/3JHY0wb

We’re presenting at the @CAR_TCell Summit tomorrow on the development of our T cell therapy intended for metastatic prostate cancer and maintaining high potency in our development of cell therapy products. bit.ly/3KBpuDJ #CellTherapy #CancerResearch #ProstateCancer

We’re developing a CAR-T cell therapy as a potential treatment for metastatic prostate cancer, for which new and more effective treatments are urgently needed. Stay tuned as we advance this program toward the clinic. More: bit.ly/3VqLxzg #ProstateCancer #CancerResearch

Join ArsenalBio scientist Sophia Phillips on July 17 at the Process Development for Cell Therapies Summit for a case study on overcoming process development challenges in solid tumor-targeting cell therapies. bit.ly/40hBPCm #CellTherapy #DrugDevelopment

On July 15 at the Process Development for Cell Therapies Summit, ArsenalBio scientist Max Lee will present during a workshop focused on implementing cutting-edge technology with phase-appropriate strategies. bit.ly/40agF90 #CellTherapy #Drug Development

Thanks to @BiotechTV and @bradloncar for sitting down with our CEO, @KDrazan , M.D., to hear about the latest on our CAR T cell therapies specifically designed to overcome the challenges presented by solid tumors. Full video available here: bit.ly/46iJPqf #CancerResearch
𝐂𝐀𝐑-𝐓 𝐋𝐨𝐠𝐢𝐜-𝐆𝐚𝐭𝐢𝐧𝐠: @ArsenalBio CEO @KDrazan describes the idea of logic-gating, which might allow CAR-T therapies to work in solid tumors when targeting more than one antigen is needed. Full interview: biotechtv.com/post/arsenalbi…


We’re honored to have @KDrazan, MD, Co-founder, CEO, and Chairman of the Board, recognized as a winner in the EY Entrepreneur Of The Year® 2025 Bay Area program. go.ey.com/4kI4eJI #EOYUS #EOYBAYAREA

Heading to Fully Connected 2025? Hear from ArsenalBio’s Sofia Panagiotopoulou as she presents “A T-cell foundation model for AI-powered target discovery and precision medicine” on June 18. Learn more and view the full agenda: bit.ly/3FINBhW

We’re proud to share that @KDrazan, MD, ArsenalBio’s Co-founder, CEO, and Chairman, has been recognized along with other inspiring business leaders as a finalist in the EY Entrepreneur Of The Year® 2025 Bay Area program. Learn more: go.ey.com/4jIJ7Xu #EOYUS #EOYBAYAREA

Future scientists at work! Each year at ArsenalBio, we hold a Bring a Kid to Work Day, where young minds explore our labs and experience the wonders of #STEM. #BringYourKidToWorkDay #TakeYourChildToWorkDay

Our One Team value extends to our local community by helping our neighbors with a cleanup day. Happy Earth Day.